leisure time -WSS

leisure time

author：fashion 2025-08-10 11:42:42 - browse：97

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Biden report: The neurospychology of memory and aging

entertainment

WSS

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Study finds gene variants tied to breast cancer risk in Black women

Reports of telehealth's death have been greatly exaggerated

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

hotspot

leisure time

entertainment

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Key House Republican on health care plans exit from Congress

Jerome Adams on the need for new antivirals for Covid

Digital health: a case of mistaken identity

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Digital health: a case of mistaken identity

Heart attack and stroke risk calculators need revising

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

23andMe had bad news about my health. I wish a person had delivered it

Investigation reveals sickle cell patients pressured into sterilizations

knowledge

The Readout: Gilead, Bernie Sanders, and other pharma news

Cue Health, Covid

Liver decline slowed by off

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Listen: More tumult at BIO & coercive care for sickle cell patients

hotspot

explore

entertainment

focus